Pancreatic Cancer Research

ResearcherUniversity Hospital HeidelbergActive in the last 2 years

Jing Tian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8490-284X; OpenAlex author ID A5001283989. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
2
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Reduced expression of CDH1 and its prognostic value in pancreatic cancer: a meta-analysis. Co-author DOI 10.5114/aoms.2020.96623↗
  2. S-1 plus CIK as second-line treatment for advanced pancreatic cancer. Last author DOI 10.1007/s12032-013-0747-9↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuan Liang Wang · 1 shared paper, 2026 · strength 0.63
  2. Meng Wang · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.